Loading
Everything OnCo dates to 1977: 24 entries, 11 landmarks, 5 technologies, 3 companies founded and 2 approvals. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
24 dated entries in OnCo fall in 1977: 11 landmarks, 5 technologies, 3 companies founded, 2 approvals, 2 journals founded and 1 law or regulation.
Of those, 24 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Brain tumours, multiple myeloma, relapsed Hodgkin and non-Hodgkin lymphoma (BiCNU)
Advanced breast cancer
The statutes, regulations, guidance and court rulings in the law index, dated to the year the instrument was made.
International, guidance.
The history entries editors wrote on cancer records: the dated turning points of each disease.
Myxofibrosarcoma
Non-seminomatous germ cell tumour
Extragonadal germ cell tumour. Einhorn's PVB regimen (cisplatin, vinblastine, bleomycin) turned a usually fatal cancer into a curable one.
Germ cell tumours of childhood and adolescence (extracranial and CNS). Einhorn's PVB regimen in testicular cancer, later adapted to children.
Seminoma
Acute myeloid leukaemia. Thomas (Seattle) reports long-term survival after HLA-matched sibling transplant; Nobel Prize 1990.
Pancreatoblastoma
Neuroendocrine and small-cell prostate cancer
Acute promyelocytic leukaemia
HR-positive / HER2-negative breast cancer. The first targeted cancer drug; later shown to reduce mortality by a third over 15 years.
High-risk early HR-positive breast cancer
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.
The founded year on company records.
Leicester
Mumbai
Ahmedabad
The founded year on journal records.
Elsevier
Oncology Nursing Society